LGC Capital (TSXV:LG) announced its Australian partner Little Green Pharma, it completed its first harvest this week.
As quoted in the press release:
LGC recently increased its strategic interest in Little Green Pharma to 14.99 [percent].
Post manufacturing and subject to the strict Therapeutic Goods Order No. 93 mandatory testing, Little Green Pharma expects to have the first Australian grown Medicinal Cannabis products available for sale both domestically and internationally.
John McMullen, CEO of LGC commented, “This is a great milestone for Little Green Pharma and their team. This is one of the first crops grown and harvested in Australia and we look forward to their unique product offering.”